Resistence to fluorquinolones and aminoglucosides in hyperproducer strains of chromosomic cephalosporinase of gram-negative bacilli with inducible beta-lactamase;Resistencia a fluorquinolonas y aminoglucósidos en cepas hiperproductoras de cefalosporinasa cromosómica de bacilos gramnegativos con betalactamasa inducible

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 14, Issue 4, 1996, Pages 211-214

  López Yeste, M Liboria ^a   Xercavins, Mariona ^a   Lite, José ^a   Cuchí, Eva ^a   Garau, Javier ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Inducible beta lactamase; Multirresistance; Prevalence stable derepressed mutants

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CEPHALOSPORINASE; PENICILLINASE; QUINOLONE DERIVATIVE; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CHROMOSOME; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ENZYME INDUCTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GRAM NEGATIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; BACTERIUM MUTANT; CHROMOSOME; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; NONHUMAN; PREVALENCE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CEPHALOSPORINASE; CHROMOSOMES, BACTERIAL; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYME INDUCTION; FLUOROQUINOLONES; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; PENICILLINASE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES;

EID: 0030113480     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Buirma RJA, Horrevorts AM, Wagenvoort JHT. Incidence of multiresistant Gram-negative isolates in eight dutch hospitals. Scand J Infect Dis 1991; Supl 78: 35-44.
2. Fuster C, Raya C, Tirado M, Teruel D, Garnelo AM, Roy C. Enterobacteriáceas 1988. Aislamientos y sensibilidad a los antibióticos betalactámicos en un hospital comarcal. Rev Esp Microbiol Clin 1991; 6: 497-503.
3. Fuster C, Roy C, Reig R, Raya C, Coira A. Frequency of Plasmid-Mediated Beta-Lactamases in Enterobacteriaccae. Isolated in Spain. Eur J Clin Microbiol Infect Dis 1993; 12: 67-69.
4. Goldstein FW, Péan Y, Rosato A, Gertner J, Gutmann L, Vigil'Roc Study Group. Characterization of ceftriaxone-resistant Enterobacteriaceae: a multicentre study in 26 French hospitals. J Antimicrob Chemother 1993; 32: 595-603.
5. Jacoby GA, Medeiros AA. More extended-spectrum ß-lactamases. Antimicrob Agents Chemother 1991; 35: 1.697-1.704.
6. Jarlier V, Nicolas M-H, Fournier G, Philippen A. Extended broad-spectrum ß-lactamases conferring transferable resistance to newer ß-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-878.
7. Liu PYF, Gur D, Hall LMC, Livermore DM. Survey of the prevalence of ß-lactamases amongst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother 1992; 30: 429-447.
8. Livermore DM. Mechanisms of resistance to ß-lactam antibiotics. Scand J Infect Dis 1991; Supl 78: 7-16.
9. López-Yeste ML, Tirado M, Reig R, Roy C. Sensibilidad a los antibióticos de Pseudomonas aeruginosa. Rev Esp Quimioterap 1992; 5: 137-141.
10. López-Yeste ML, Chaves J, Garau J, Martín A, Tirado M, Reig R, Roy C. Pérdida de sensibilidad a los antibióticos de cepas de Pseudomonas aeruginosa en el curso del tratamiento. Med Clin (Barc) 1994; 103: 81-84.
11. Reeves DS, Bywater MJ, Holt HA. The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres. J Antimicrob Chemother 1993; 31: 345-362.
12. Roy C, Reig R, Chaves J, González-Arqueros J. Betalactamasas cromosómicas. En: Gómez-Lus R, Garau J, eds. Betalactamasas: su importancia para el clínico. Madrid: Smith Kline & French S.A.E., 1992.
13. Roy C, Tirado M, Segura C, Esteva C, Teruel D. Detección de la hiperproducción de betalactamasa cromosómica en cepas de Escherichia coli, Enterobacter cloacae y Pseudomonas aeruginosa. Enferm Infecc Microbiol Clin 1989; 7: 301-306.
14. Sanders WE, Sanders CC. Inducible ß-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. Rev Infect Dis 1988; 10: 830-838.
15. Segura C, Roy C. Betalactamasas. En: Viñas M, Regué R, Lorén JG, eds. Envueltas bacterianas y antibióticos. LCT-18. Barcelona: PPU, 1991; 84-99.
16. Snydman DR. Clinical implications of multi-drug resistance in the intensive care unit. Scand J Infect Dis 1991; Supl 78: 54-63.
17. Tirado M, Hermida M, Reig R, Esteva C, Vidal R, Roy C. Resistencia por hiperproducción de betalactamasa cromosómica en Pseudomonas aeruginosa. Enferm Infecc Microbiol Clin 1989; 7: 530-534.
18. Verbist L. Incidence of multi-resistance in Gram-negative bacterial isolates from intensive care units in Belgium: a surveillance study. Scand J Infect Dis 1991; Supl 78: 45-53.
19. National Committee for Clinical Laboratory Standards. Performance standars for antimicrobial susceptibility testing. NCCLS Document M100-S4 (ISBN 1-56238-136-9). NCCLS, 771. E. Lancaster Avenue, Villanova, Pennsylvania 19085, 1992.
20. Chow JW, Fine MJ, Shalaes DM, Quinn JP, Hopper DC, Johnson MP et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-590.
21. Sanders C. New beta-lactams: new problems for the internist. Ann Intern Med 1991; 115: 650-651.